Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07399002 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

LONG NAGOMI™ PMCF STUDY

Study acronym: LONG NAGOMI
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 8 to 10v11
  2. Study sites: 7 to 8v10
  3. Study sites: 6 to 7v9
  4. Study sites: 4 to 6v8
  5. Trial status: Not Yet Recruiting to Recruiting Start date: Feb 28, 2026 to Feb 27, 2026 · Site details revised at 4 of 4 sitesv7 Show 2 more changesShow less
    • Start date: Feb 28, 2026 to Feb 27, 2026
    • Site details revised at 4 of 4 sites
Show 5 earlier versionsHide 5 earlier versions
  1. Study sites: 3 to 4v6
  2. Study sites: 2 to 3v5
  3. Study sites: 3 to 2v4
  4. Study sites: 2 to 3v3
  5. Study sites: 0 to 2v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study is designed as a prospective, multi-center, observational PMCF (post-market clinical follow-up) study of the Ultimaster Nagomi™ \_stent (lengths of 38, 44 and 50 mm) in the treatment of coronary artery disease according to the indications approved in the CE marking.
Trial Details
NCT Number NCT07399002
Lead Sponsor Fundación EPIC
Conditions Coronary Artery Disease, Ischemic Heart Disease
Enrollment 1,039 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov